Safety and Immunogenicity of the Butantan Institute Influenza Vaccine Compared to Sanofi Pasteur Influenza Vaccine
Clinical trial NCT03777163 · COMPLETED
Trial details
- NCT number
- NCT03777163
- Sponsor
- Butantan Institute
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2020-01-15
- Enrollment
- 632
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.